]>
IRCT20181218042033N2 IRCT 2020-02-24 Bandare-abbas University of Medical Sciences Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management pregnancy terminations with IUFD Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management of second trimester pregnancy terminations with IUFD in khalij fars hospital in Bandar Abbas in 2018. 2019-03-18 anticipated 106 Complete https://irct.ir/trial/45421 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple, block randomization, Blinding description: Participants are no longer aware of the misoprostol or oxytosin recipes. 2 Intrauterine fetal death. Intervention 1: Intervention group: Vaginal misoprostol: 400 μg every 6 hours up to 48 hours. Intervention 2: Control group: Oxytocin at a dose of 50 units of oxytocin at 500 cc Ringer (up to a maximum dose of 300 units). Yes - There is a plan to make this available What will be shared: IPD: Information and research data Ethic form: Complete the ٍEthic form by the patient When: IPD: 2018 Ethic form: 2018 To whom: IPD: Researcher & Patient Ethic form: Patient Conditions: IPD: Ethic form: Awareness of test results Where to obtain: IPD: OB & Gyn ward Hormozgan university of medical sciences Ethic form: OB & Gyn ward Hormozgan university of medical sciences How to obtain: IPD: Vice chancellery Ethic form: Vice chancellery Comments:
public Atena Gisooee
Hormozgan University Of Medical Sciences, Chamran Blvd, Bandar abbas
Bandar Abbas Iran (Islamic Republic of) 7916839319 +98 76 3647 9830 gisooeeatena@yahoo.com Bandare-abbas University of Medical Sciences scientific Bandare-abbas University of Medical Sciences
Hormozgan University Of Medical Sciences, Chamran Blvd, Bandar abbas
Bandar Abbas Iran (Islamic Republic of) 7916839319 +98 736479830 abdinazanin834@gmail.com Bandare-abbas University of Medical Sciences Iran (Islamic Republic of) Pregnant women with 18 to 40 years of age confirmed by IUFD gestational age of 15 to 26 weeks 18 years 40 years Female Multiparty more than 6 Coagulopathy Multi fetal pregnancy Any obstacle to induction of labor (e.g. maternal heart disease, clinical chorioamnionitis, vasa previa, placenta previa, invasive cervical carcinoma, myoma surgery or any surgery that has cut the uterine) Having one or more caesarean section History of any uterine incision (myomectomy and etc.). O04 Complications following (induced) termination of pregnancy Treatment - Drugs Treatment - Drugs Intervention group: Vaginal misoprostol: 400 μg every 6 hours up to 48 hours Control group: Oxytocin at a dose of 50 units of oxytocin at 500 cc Ringer (up to a maximum dose of 300 units) Induction- to-delivery interval time. Timepoint: 6-48 hours after misoprostol and oxytocin administration. Method of measurement: clock. Bandare-abbas University of Medical Sciences Approved 2019-03-17 Ethics committee of Homozgan University of medical sciences Hormozgan University Of Medical Sciences, Chamran Blvd, Bandar abbas Bandar Abbas Hormozgan Iran (Islamic Republic of)